Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma

被引:172
作者
Bachert, Collin
Fimmel, Claus
Linstedt, Adam D. [1 ]
机构
[1] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA
[2] Loyola Univ, Stitch Sch Med, Div Gastroenterol Hepatol & Nutr, Maywood, IL 60153 USA
关键词
biomarker; Golgi; GP73; endosome; furin; hepatocellular carcinoma;
D O I
10.1111/j.1600-0854.2007.00621.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Serum GP73 levels are significantly increased in patients with hepatocellular carcinoma (HCC), potentially providing a marker for early detection. However, GP73 is an integral membrane protein localized to the cis Golgi and is not known to be secreted. Based on its presence in sera, we sought to determine whether GP73 might normally be released from cells and to elucidate the mechanism of this release. Indeed, a soluble form of GP73 was released from cultured cells and compared with the Golgi-localized full-length protein, the molecular weight was slightly reduced, suggesting that cleavage releases the GP73 ectodomain. Sequence analysis revealed a proprotein convertase (PC) consensus site, and, indeed, the ubiquitous PC furin was capable of cleaving purified GP73. Further, alanine substitutions in the PC site blocked both the in vitro and the in vivo cleavage of GP73. Using a cleavage-specific antibody, cleaved GP73 was found in the trans Golgi network and endosomes, suggesting that GP73 cleavage occurs as GP73 cycles distal to the early Golgi. We conclude that the endosomal trafficking of GP73 allows for PC-mediated cleavage, resulting in GP73 secretion, and provides a molecular mechanism for its presence as a serum biomarker for HCC.
引用
收藏
页码:1415 / 1423
页数:9
相关论文
共 43 条
[1]   TGF-β signaling in cancer -: a double-edged sword [J].
Akhurst, RJ ;
Derynck, R .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S44-S51
[2]  
[Anonymous], 1988, A Laboratory Manual
[3]   Proprotein convertases: "Master switches" in the regulation of tumor growth and progression [J].
Bassi, DE ;
Fu, J ;
de Cicco, RL ;
Klein-Szanto, AJP .
MOLECULAR CARCINOGENESIS, 2005, 44 (03) :151-161
[4]   Increased furin activity enhances the malignant phenotype of human head and neck cancer cells [J].
Bassi, DE ;
Mahloogi, H ;
De Cicco, RL ;
Klein-Szanto, A .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (02) :439-447
[5]   Elevated furin expression in aggressive human head and neck tumors and tumors cell lines [J].
Bassi, DE ;
Mahloogi, H ;
Al-Saleem, L ;
De Cicco, RL ;
Ridge, JA ;
Klein-Szanto, AJP .
MOLECULAR CARCINOGENESIS, 2001, 31 (04) :224-232
[6]   Involvement of Smads in TGFβ1-induced furin (fur) transcription [J].
Blanchette, F ;
Rudd, P ;
Grondin, F ;
Attisano, L ;
Dubois, CM .
JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 188 (02) :264-273
[7]   Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans [J].
Block, TM ;
Comunale, MA ;
Lowman, M ;
Steel, LF ;
Romano, PR ;
Fimmel, C ;
Tennant, BC ;
London, WT ;
Evans, AA ;
Blumberg, BS ;
Dwek, RA ;
Mattu, TS ;
Mehta, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (03) :779-784
[8]   Polyarginines are potent furin inhibitors [J].
Cameron, A ;
Appel, J ;
Houghten, RA ;
Lindberg, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (47) :36741-36749
[9]  
Cheng M, 1997, INT J CANCER, V71, P966, DOI 10.1002/(SICI)1097-0215(19970611)71:6<966::AID-IJC10>3.3.CO
[10]  
2-A